Advertisement

Annals of Hematology

, Volume 92, Issue 5, pp 699–705 | Cite as

Outcome of critically ill patients with hematological malignancies

  • Silvio A. Ñamendys-SilvaEmail author
  • María O. González-Herrera
  • Francisco J. García-Guillén
  • Julia Texcocano-Becerra
  • Angel Herrera-Gómez
Original Article

Abstract

The prognosis for patients with hematological malignancies (HMs) admitted to the intensive care unit (ICU) is poor. The objective of this study was to evaluate the clinical characteristics and hospital outcomes of critically ill patients with HMs admitted to an oncological ICU. This is a prospective, observational cohort study. A total of 102 patients with HMs admitted to ICU from January 2008 to April 2011 were included. Univariate and multivariate logistic regressions were used to identify factors associated with hospital mortality. During the study period, 3,776 patients with HM were admitted to the Department of Hematology of the Instituto Nacional de Cancerología located in Mexico City, Mexico. After being evaluated by the intensivist, 102 (2.68 %) patients were admitted to the ICU. The ICU mortality rates for patients who had two or less organ system failures and for those with three or more organ system dysfunctions were 20 % (5/25) and 70.1 % (54/77), respectively (P < 0.0001). A multivariate analysis identified independent prognostic factors of inhospital death as neutropenia at the time of ICU admission (odds ratio (OR), 4.24; 95 % confidence interval (CI), 1.36–13.19, P = 0.012), the need for vasopressors (OR, 4.49; 95 % CI, 1.07–18.79, P = 0.040), need for invasive mechanical ventilation (OR, 4.49; 95 % CI, 1.07–18.79, P = 0.040), and serum creatinine >106 μmol/L (OR, 3.21; 95 % CI, 1.05–9.85, P = 0.041). The ICU and hospital mortality rates were 46.1 and 57.8 %, respectively. The independent prognostic factors of inhospital death were the need for invasive mechanical ventilation, the need for vasopressors, serum creatinine >106 μmol/L, and neutropenia at the time of ICU admission.

Keywords

Outcomes Hematological malignancies Critically ill patients Intensive care unit Critical care 

Notes

Acknowledgments

We thank the nurses and medical staff of the intensive care unit at INCan, Mexico City, who were involved in the care of these patients for their assistance.

Conflict of interest

The authors declared that they have no conflict of interest.

References

  1. 1.
    Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235–242PubMedCrossRefGoogle Scholar
  2. 2.
    O'Brien SG, Guilhot F, Larson RA et al (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348(11):994–1004PubMedCrossRefGoogle Scholar
  3. 3.
    Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC (2012) Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 108(3):452–459PubMedCrossRefGoogle Scholar
  4. 4.
    Geerse DA, Span LF, Pinto-Sietsma SJ, van Mook WN (2011) Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med 22(1):57–61PubMedCrossRefGoogle Scholar
  5. 5.
    Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL (2009) Characteristics and outcomes of cancer patients in European ICUs. Crit Care 13(1):R15PubMedCrossRefGoogle Scholar
  6. 6.
    Massion PB, Dive AM, Doyen C et al (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30(10):2260–2270PubMedCrossRefGoogle Scholar
  7. 7.
    Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA (2008) Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care 12(3):R77PubMedCrossRefGoogle Scholar
  8. 8.
    Owczuk R, Wujtewicz MA, Sawicka W, Wadrzyk A, Wujtewicz M (2005) Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit. Support Care Cancer 13(5):332–338PubMedCrossRefGoogle Scholar
  9. 9.
    Hampshire PA, Welch CA, McCrossan LA, Francis K, Harrison DA (2009) Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 13(4):R137PubMedCrossRefGoogle Scholar
  10. 10.
    Namendys-Silva SA, Texcocano-Becerra J, Herrera-Gómez A (2010) Prognostic factors in critically ill patients with solid tumor admitted to an oncological intensive care unit. Anaesth Intensiv Care 38:317–324Google Scholar
  11. 11.
    Ñamendys-Silva SA, González-Herrera MO, Texcocano-Becerra J, Herrera-Gómez A (2011) Clinical characteristics and outcomes of critically ill cancer patients with septic shock. QJM 104(6):505–511PubMedCrossRefGoogle Scholar
  12. 12.
    Thiéry G, Azoulay E, Darmon M et al (2005) Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 23:4406–4413PubMedCrossRefGoogle Scholar
  13. 13.
    Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E (2007) The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 35:808–814PubMedCrossRefGoogle Scholar
  14. 14.
    Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655PubMedCrossRefGoogle Scholar
  15. 15.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13(10):818–829PubMedCrossRefGoogle Scholar
  16. 16.
    Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707–710PubMedCrossRefGoogle Scholar
  17. 17.
    Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270(24):2957–2963PubMedCrossRefGoogle Scholar
  18. 18.
    Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655PubMedCrossRefGoogle Scholar
  19. 19.
    Kuehnhardt D, Hannemann M, Schmidt B, Heider U, Possinger K, Eucker J (2009) Therapeutic implication of BAL in patients with neutropenia. Ann Hematol 88(12):1249–1256PubMedCrossRefGoogle Scholar
  20. 20.
    Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327PubMedCrossRefGoogle Scholar
  21. 21.
    Hanley JA, McNeil BJ (1982) The meaning and use of the area under receiver operating characteristic (ROC) curve. Radiology 143(1):29–36PubMedGoogle Scholar
  22. 22.
    Hosmer DW, Taber S, Lemeshow S (1991) The importance of assessing the fit of logistic regression models: a case study. Am J Public Health 81(12):1630–1635PubMedCrossRefGoogle Scholar
  23. 23.
    Lamia B, Hellot MF, Girault C et al (2006) Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU. Intensive Care Med 32(10):1560–1568PubMedCrossRefGoogle Scholar
  24. 24.
    Khassawneh BY, White P Jr, Anaissie EJ, Barlogie B, Hiller FC (2002) Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 121(1):185–188PubMedCrossRefGoogle Scholar
  25. 25.
    Depuydt PO, Benoit DD, Roosens CD, Offner FC, Noens LA, Decruyenaere JM (2010) The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure. J Crit Care 25(1):30–36PubMedCrossRefGoogle Scholar
  26. 26.
    Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24(24):4003–4010PubMedCrossRefGoogle Scholar
  27. 27.
    Maccariello E, Valente C, Nogueira L et al (2011) Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units. Nephrol Dial Transplant 26(2):537–543PubMedCrossRefGoogle Scholar
  28. 28.
    Cornet AD, Issa AI, van de Loosdrecht AA et al (2005) Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 74(6):511–516PubMedCrossRefGoogle Scholar
  29. 29.
    Peigne V, Rusinová K, Karlin L et al (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35(3):512–518PubMedCrossRefGoogle Scholar
  30. 30.
    Legrand M, Max A, Peigne V et al (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40(1):43–49PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Silvio A. Ñamendys-Silva
    • 1
    • 2
    Email author
  • María O. González-Herrera
    • 1
  • Francisco J. García-Guillén
    • 1
  • Julia Texcocano-Becerra
    • 1
  • Angel Herrera-Gómez
    • 3
  1. 1.Department of Critical Care MedicineInstituto Nacional de CancerologíaMexico CityMexico
  2. 2.Department of Critical Care MedicineInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico CityMexico
  3. 3.Division of Surgical OncologyInstituto Nacional de CancerologíaMexico CityMexico

Personalised recommendations